These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15320754)

  • 1. The opioid receptor independent actions of kappa receptor agonists in the cardiovascular system.
    Pugsley MK
    Curr Pharm Des; 2004; 10(20):2429-44. PubMed ID: 15320754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system.
    Pugsley MK
    Pharmacol Ther; 2002 Jan; 93(1):51-75. PubMed ID: 11916541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Butorphanol: effects of a prototypical agonist-antagonist analgesic on kappa-opioid receptors.
    Commiskey S; Fan LW; Ho IK; Rockhold RW
    J Pharmacol Sci; 2005 Jun; 98(2):109-16. PubMed ID: 15942128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central and peripheral actions of the novel kappa-opioid receptor agonist, EMD 60400.
    Barber A; Bartoszyk GD; Greiner HE; Mauler F; Murray RD; Seyfried CA; Simon M; Gottschlich R; Harting J; Lues I
    Br J Pharmacol; 1994 Mar; 111(3):843-51. PubMed ID: 8019761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753.
    Barber A; Bartoszyk GD; Bender HM; Gottschlich R; Greiner HE; Harting J; Mauler F; Minck KO; Murray RD; Simon M
    Br J Pharmacol; 1994 Dec; 113(4):1317-27. PubMed ID: 7889287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed κ/μ partial opioid agonists as potential treatments for cocaine dependence.
    Bidlack JM
    Adv Pharmacol; 2014; 69():387-418. PubMed ID: 24484983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
    Yu XC; Wang HX; Pei JM; Wong TM
    J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crucial role of peripheral kappa-opioid receptors in a model of periodontal disease in rats.
    Pacheco CM; Queiroz-Junior CM; Maltos KL; Caliari MV; Pacheco DF; Duarte ID; Francischi JN
    J Periodontal Res; 2008 Dec; 43(6):730-6. PubMed ID: 18705652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel κ-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedation.
    Zhang LS; Wang J; Chen JC; Tao YM; Wang YH; Xu XJ; Chen J; Xu YG; Xi T; Hu XW; Wang YJ; Liu JG
    Acta Pharmacol Sin; 2015 May; 36(5):565-71. PubMed ID: 25816912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kappa opioids and the modulation of pain.
    Kivell B; Prisinzano TE
    Psychopharmacology (Berl); 2010 Jun; 210(2):109-19. PubMed ID: 20372880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arylacetamides as peripherally restricted kappa opioid receptor agonists.
    Kumar V; Marella MA; Cortes-Burgos L; Chang AC; Cassel JA; Daubert JD; DeHaven RN; DeHaven-Hudkins DL; Gottshall SL; Mansson E; Maycock AL
    Bioorg Med Chem Lett; 2000 Nov; 10(22):2567-70. PubMed ID: 11086731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
    Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
    J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor.
    Pan ZZ; Tershner SA; Fields HL
    Nature; 1997 Sep; 389(6649):382-5. PubMed ID: 9311779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.
    Morgenweck J; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():600-9. PubMed ID: 26318102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. kappa-Opioid receptor agonist protects against ischemic reduction of 2-deoxyglucose uptake in morphine-tolerant rats.
    Shibata S; Tominaga K; Watanabe S
    Eur J Pharmacol; 1995 Jun; 279(2-3):197-202. PubMed ID: 7556401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FE200041 (D-Phe-D-Phe-D-Nle-D-Arg-NH2): A peripheral efficacious kappa opioid agonist with unprecedented selectivity.
    Vanderah TW; Schteingart CD; Trojnar J; Junien JL; Lai J; Riviere PJ
    J Pharmacol Exp Ther; 2004 Jul; 310(1):326-33. PubMed ID: 14993260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of exogenous kappa-opioid receptor activation in rat model of myocardial infarction.
    Peart JN; Gross ER; Gross GJ
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):410-5. PubMed ID: 15076225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and structure-activity relationship of novel opioid kappa-agonists.
    Kawai K; Hayakawa J; Miyamoto T; Imamura Y; Yamane S; Wakita H; Fujii H; Kawamura K; Matsuura H; Izumimoto N; Kobayashi R; Endo T; Nagase H
    Bioorg Med Chem; 2008 Oct; 16(20):9188-201. PubMed ID: 18829333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.